14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CHYM vs ABTC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over American Bitcoin Corp. (ABTC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CHYM carries a Unified Composite Score of 33.1/100 (SELL) at $34.29 (31.6x Forward P/E, 19.3% operating margin), whereas ABTC carries 59.1/100 (HOLD) at $4.71 (4.9x Forward P/E, -38.7% operating margin).
Composite vs. Pillar Nuance: While ABTC currently prints a higher short-term Unified Composite Score (59.1/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.3% vs. -38.7% operating margin) and revenue trajectory (+32.1% vs. -1.3% YoY).
Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.1); meanwhile ABTC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Capital Markets value chain with $369.2M market capitalization and -38.7% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CHYM vs ABTC Key Questions & Quantitative Answers
As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over American Bitcoin Corp. (ABTC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CHYM carries a Unified Composite Score of 33.1/100 (SELL) at $34.29 (31.6x Forward P/E, 19.3% operating margin), whereas ABTC carries 59.1/100 (HOLD) at $4.71 (4.9x Forward P/E, -38.7% operating margin). Composite vs. Pillar Nuance: While ABTC currently prints a higher short-term Unified Composite Score (59.1/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.3% vs. -38.7% operating margin) and revenue trajectory (+32.1% vs. -1.3% YoY). Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.1); meanwhile ABTC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CHYM leads the Growth & Scale pillar: CHYM posts +32.1% YoY revenue growth and -33.8% YoY earnings growth on $14.3B TTM revenue (89.4% gross margin, 19.3% operating margin), compared with ABTC at -1.3% YoY revenue growth and N/A YoY earnings growth on $271M TTM revenue (49.1% gross margin, -38.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CHYM cumulative revenue shifted +71.1% while ABTC shifted +1800.0%. In operating R&D and SG&A reinvestment, CHYM deploys 70.1% of Rev ($10.1B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABTC.
ABTC screens cheaper on headline valuation multiples. CHYM trades at 31.6x Forward P/E, 29.4x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (15.8% FCF margin), whereas ABTC trades at 4.9x Forward P/E, 3.5x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (-41.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CHYM (5.4% ROE) versus ABTC (-10.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CHYM carries 48.7% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.44β · 36% Vol realized risk). By comparison, ABTC carries 150.4% implied volatility (9th %ile, Compressed (<25th %ile)), a 0.05x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (11.45β · 103% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.